期刊
NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-08261-z
关键词
-
资金
- Canadian Institutes of Health Research (CIHR Project Grant)
- Medicine-by-Design Cycle 1 Team Projects Award [C1TPA-2016-07]
- Toronto General & Western Hospital Foundation [1013612]
- XVIVO Perfusion
- Brazilian agency Sao Paulo Research Foundation) [FAPESP CEPOF 2013/07276-1, INCT 2014/50857-8]
- Brazilian agency National Council for Scientific and Technological Development [CNPq 465360/2014-9]
Availability of organs is a limiting factor for lung transplantation, leading to substantial mortality rates on the wait list. Use of organs from donors with transmissible viral infections, such as hepatitis C virus (HCV), would increase organ donation, but these organs are generally not offered for transplantation due to a high risk of transmission. Here, we develop a method for treatment of HCV-infected human donor lungs that prevents HCV transmission. Physical viral clearance in combination with germicidal light-based therapies during normothermic ex-vivo Lung Perfusion (EVLP), a method for assessment and treatment of injured donor lungs, inactivates HCV virus in a short period of time. Such treatment is shown to be safe using a large animal EVLP-to-lung transplantation model. This strategy of treating viral infection in a donor organ during preservation could significantly increase the availability of organs for transplantation and encourages further clinical development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据